房颤患者口服抗凝药长期依从性轨迹研究
该研究基于加拿大不列颠哥伦比亚省1996-2019年行政健康数据,纳入19,749例新发房颤患者,采用组基轨迹模型识别5年口服抗凝药依从性轨迹,发现4种不同轨迹,且临床和人口学特征难以预测依从性轨迹。
要点
- 房颤患者5年口服抗凝药依从性存在4种不同轨迹。
- 多数患者(74%)表现为持续依从,少数呈快速或缓慢下降。
- 临床和人口学因素不足以预测患者依从性轨迹。
核心结论
- 非依从患者在用药减少的速度和时机上存在异质性。
- 临床和人口学特征不足以预测患者的依从性轨迹。
研究设计与样本
- 基于加拿大不列颠哥伦比亚省关联人口行政健康数据的回顾性队列研究,纳入1996-2019年新发房颤成人患者。
- 采用组基轨迹模型对患者90天覆盖天数比例随时间建模,识别5年依从性轨迹。
- 采用多项回归分析评估人口学和临床因素对依从性轨迹的影响。
主要发现
- 研究队列包含19,749例房颤患者,平均年龄70.6±10.6岁,56%为男性,平均CHA2DS2-VASc卒中风险评分2.8±1.4。
- 组基轨迹模型识别出4种口服抗凝药依从性轨迹:持续依从(n=14,631,占74%)、快速下降并停药(n=2,327,占12%)、快速下降后部分恢复(n=1,973,占10%)、缓慢下降并停药(n=819,占4%)。
- 极少患者变量与特定依从性轨迹相关。
临床怎么用
- 研究结果可用于指导依从性干预的设计和时机选择。
- 可能需要定性研究以更好地理解 psychosocial 决定因素及轨迹行为的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional adherence summary measures do not capture the dynamic nature of adherence. OBJECTIVES: This study aims to characterize distinct long-term oral anticoagulant adherence trajectories and the factors associated with them in patients with atrial fibrillation. METHODS: Adults with incident atrial fibrillation were identified using linked population-based administrative health data in British Columbia, Canada (1996-2019). Group-based trajectory modeling was used to model patients' 90-day proportions of days covered over time to identify distinct 5-year adherence trajectories. Multinomial regression analysis was used to assess the effect of various demographic and clinical factors on exhibiting each adherence trajectory. RESULTS: The study cohort included 19,749 patients with AF (mean age: 70.6 ± 10.6 years), 56% male, mean CHA2DS2-VASc stroke risk score 2.8 ± 1.4. Group-based trajectory modeling identified 4 distinct oral anticoagulants adherence trajectories: "consistent adherence" (n = 14,631, 74% of the cohort), "rapid decline and discontinuation" (n = 2,327, 12%), "rapid decline and partial recovery" (n = 1,973, 10%), and "slow decline and discontinuation" (n = 819, 4%). Very few patient variables were found to be associated with specific adherence trajectories. CONCLUSIONS: There is heterogeneity among nonadherent patients in the rate and timing of decline in their medication taking. Clinical and demographic characteristics were found to be inadequate to predict patients' adherence trajectories. Insights from this study could be used to inform the design and timing of adherence interventions, and qualitative studies may be needed to better understand the psychosocial determinants and reasons for the behaviors reflected in the identified trajectories.
引用
- Salmasi, De Vera, Safari, et al. Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021. PMID: 34886959. doi:10.1016/j.jacc.2021.09.1370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。